• Explore /
  • Poster
  • / SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, hormone receptor (HR)-positive, and HER2-negative breast cancer with recurrence score (RS) of 25 or less.

SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, hormone receptor (HR)-positive, and HER2-negative breast cancer with recurrence score (RS) of 25 or less.

Abstract Poster

Authors

null

A. M. Gonzalez-Angulo

M. D. Anderson Cancer Center, Houston, TX

A. M. Gonzalez-Angulo , W. E. Barlow , J. Gralow , F. Meric-Bernstam , D. F. Hayes , C. Moinpour , S. D. Ramsey , A. F. Schott , D. B. Sparks , K. S. Albain , G. N. Hortobagyi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session

Track

Special Sessions,Clinical Trials

Sub Track

ER+

Clinical Trial Registration Number

NCT01272037

Citation

J Clin Oncol 29: 2011 (suppl; abstr TPS104)

Abstract #

TPS104

Poster Bd #

36F

Abstract Disclosures

Similar Posters

First Author: Yukinori Ozaki

First Author: Charles Geyer

First Author: Christopher David Walden

First Author: Seock-Ah Im